ARDENT HEALTH INC (ARDT:NYSE)
$10.81 -0.19 (-1.7273%)
Analysed ARDENT HEALTH INC (ARDT:NYSE) News Sources
Ardent Health Inc (ARDT) (Q2 2026) Earnings Call Highlights: Raising Impact Program Savings ...
05-08-2026
yahoo.com
Is Ardent Health (ARDT) Cheap On Lowered Guidance And Weaker Q2 Earnings?
08-08-2026
yahoo.com
Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region
11-08-2026
yahoo.com
Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
27-08-2026
yahoo.com
Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine
02-09-2026
yahoo.com
Ardent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy?
28-07-2026
yahoo.com
Ardent Health (ARDT) Q2 2026 Earnings Call Transcript
11-08-2026
fool.com
Implied Volatility Surging for Ardent Health Stock Options
13-08-2026
yahoo.com
HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP)
14-09-2026
yahoo.com
Ardent Health Hospitals Earn Recognition in U.S. News & World Report’s 2026-2027 Best Hospitals Rankings
15-09-2026
yahoo.com
What is the current price of ARDENT HEALTH INC (ARDT:NYSE)?
The current price of ARDENT HEALTH INC (ARDT:NYSE) is $10.81.
ARDENT HEALTH INC (ARDT:NYSE) absolute price change since previous trading day?
The absolute price change of ARDENT HEALTH INC (ARDT:NYSE) since the previous trading day is $-0.19.
ARDENT HEALTH INC (ARDT:NYSE) percentage price change since previous trading day?
The percentage price change of ARDENT HEALTH INC (ARDT:NYSE) since the previous trading day is -1.7273%.
What is the most recent average sentiment score for ARDENT HEALTH INC (ARDT:NYSE)?
The most recent average sentiment score for ARDENT HEALTH INC (ARDT:NYSE) is 70 out of 100.
What is the most recent average sentiment for ARDENT HEALTH INC (ARDT:NYSE)?
The most recent sentiment for ARDENT HEALTH INC (ARDT:NYSE) is .
SEC-8K** Filing Available For ARDENT HEALTH INC (ARDT:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.